TScan Therapeutics TCRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.82 | 105.83 | -0.27 | -37,052 | -36 | |
| 2025Q2 | 1.45 | 106.59 | -0.28 | -38,653 | -37 | |
| 2025Q1 | 1.38 | 108.38 | -0.26 | -36,250 | -34 | |
| 2024Q4 | 3.04 | 104.82 | -0.30 | -36,712 | -36 | |
| 2024Q3 | 4.98 | 112.77 | -0.25 | -32,622 | -30 | |
| 2024Q2 | 5.85 | 111.09 | -0.27 | -34,114 | -32 | |
| 2024Q1 | 7.94 | 107.50 | -0.32 | -31,373 | -30 | |
| 2023Q4 | 5.83 | 113.84 | -0.11 | -21,357 | -20 | |
| 2023Q3 | 2.56 | 112.41 | 0.05 | -24,748 | -23 | |
| 2023Q2 | 2.50 | 106.65 | -0.37 | -24,610 | -24 | |
| 2023Q1 | 2.10 | 105.26 | -0.93 | -22,743 | -23 | |
| 2022Q4 | 1.55 | 105.08 | -0.77 | -18,649 | -19 | |
| 2022Q3 | 3.05 | 103.33 | -0.68 | -16,578 | -16 | |
| 2022Q2 | 3.15 | 100.99 | -0.63 | -15,246 | -15 | |
| 2022Q1 | 2.80 | -0.67 | -16,163 | -16 | ||
| 2021Q4 | 4.50 | 0.38 | -14,202 | -14 | ||
| 2021Q3 | 8.34 | 9.70 | -15,842 | -16 | ||
| 2021Q2 | -7.76 | -10,679 | -11 | |||
| 2021Q1 | 100.08 | -6.49 | -7,918 | -8 | ||
| 2020Q4 | -7,810 | -8 |